TelconRF Pharmaceutical: Capital Reduction to Cover Deficits
-
Capital reduction to cover deficits; proceeds by ordinary resolution, skipping creditors' objection procedure
-
Fractional shares from consolidation to be paid in cash at closing price on first listing day of new shares
-
Reduction details may change based on the outcome of a third-party allocation paid-in capital increase scheduled for April 17, 2026
KOSDAQ Filing Information
-
Filing: Current Report (Capital Reduction Decision)
-
Company: Telcon RF Pharmaceutical (200230)
-
Submission: Telcon RF Pharmaceutical. Inc.
-
Receipt: 04-08-2026
-
Amended (Refer to related filing)